Market Executive Summary

In 2024, the global market size of Digital Pathology was estimated to be worth US$ 931 million and is forecast to reach approximately US$ 2178 million by 2031 with a CAGR of 13.1% during the forecast period 2025-2031.

Digital Pathology, which also refers as virtual microscopy, incorporates capturing, sharing, managing, interpreting and analysing the digital information from a glass slide. Pathology is a study of disease whether caused by pathogens or non- infectious, physical disorder; it refers to the scientific study of disease processes; it occupies a vital role in all type of drug discoveries. Digital pathology technology is widely used in the scanners, software, communication systems and storage systems and helps in the improvement of operational efficiency, enhancing productivity, developments in treatment decisions and patient care. In the year 1990s principle of virtual microscopy is used in the life science areas, and in the year 2000 scientific community agreed the term digital pathology denote digitisation efforts in pathology and later digital pathology technology is used in the various kind of applications.

The digital pathology market is experiencing significant growth and transformation, influenced by technological advancements, evolving healthcare needs, and increasing adoption of digital solutions in pathology.

Here are the key trends shaping this market:

1. Growing Demand for Telepathology

The shift towards telehealth, accelerated by the COVID-19 pandemic, has driven demand for telepathology solutions. Digital pathology systems facilitate remote consultations and collaborations, enabling pathologists to access and review cases from various locations.

2. Technological Advancements

Continuous innovations in imaging technology, such as higher-resolution scans, faster processing speeds, and improved automation, are enhancing the capabilities of digital pathology systems. The integration of artificial intelligence (AI) and machine learning is also revolutionizing image analysis and diagnostics.

3. Regulatory Approvals and Support

Increasing regulatory approvals for digital pathology systems for primary diagnosis are fostering confidence in these technologies. Regulatory bodies like the FDA are recognizing the potential of digital pathology, encouraging wider acceptance in clinical practice.

4. Investment in Healthcare IT Infrastructure

Healthcare institutions are investing heavily in digital solutions to modernize their pathology labs. This trend aims to improve laboratory efficiency, accuracy, and patient care, driving demand for digital pathology systems.

5. Focus on Personalized Medicine

Digital pathology plays a crucial role in personalized medicine by integrating pathology data with genomic and clinical information. This trend is promoting the development and adoption of systems that support tailored treatment approaches.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Digital Pathology, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Digital Pathology.

The Digital Pathology market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Digital Pathology market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Digital Pathology companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, product type, application, and regions.

Global Digital Pathology Companies Covered

Danaher, Hamamatsu Photonics, Roche, Philips, Olympus, PerkinElmer, Sectra, Nikon, Definiens, 3DHISTECH, Visiopharm, Apollo Enterprise Imaging, Glencoe Software, Indica Labs, OptraSCAN, Objective Pathology, Digipath, Pathcore

Global Digital Pathology Market, by Region

North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)

Global Digital Pathology Market, Segment by Type

Whole Slide Imaging

Image Analysis-Informatics

Information Management System Storage & Communication

Digital IVD Devices

Others

Global Digital Pathology Market, Segment by Application

Pharma & Biotech Companies

Hospital & Diagnostic Centers

Educational Institutes

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on.

Chapter 2: Revenue of Digital Pathology in global and regional level.

Chapter 3: Detailed analysis of Digital Pathology company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Digital Pathology revenue, gross margin, and recent development, etc.

Chapter 5: Provides the analysis of various market segments by Type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by Application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: North America (US & Canada) by Type, by Application and by country, revenue for each segment.

Chapter 8: Europe by Type, by Application and by country, revenue for each segment.

Chapter 9: Asia Pacific by Type, by Application and by region, revenue for each segment.

Chapter 10: Latin America by Type, by Application and by country, revenue for each segment.

Chapter 11: Middle East and Africa, by Type, by Application and by country, revenue for each segment.

Chapter 12: Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.

Chapter 13: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 14: Research Findings and Conclusion

related reports:

Global Laboratory Developed Test Market Size, Share, Growth Drivers, Competitive Analysis, Overall Sales and Demand Forecast To 2030

Global Laboratory Chemical Reagents Market Size, Share, Growth Drivers, Opportunities, Recent Developments, and Forecast To 2030